Reply to: Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?

Nature Reviews Rheumatology, Published online: 21 August 2023; doi:10.1038/s41584-023-01014-3Reply to: Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?

Source: Nature Reviews Rheumatology - August 21, 2023 Category: Rheumatology Authors: Janet E. Pope Source Type: research